… In populations such as children, the elderly, obese patients, those … of continuous medication
> 2 days; (4) at least one steady-state … Is prolonged infusion of piperacillin/tazobactam and …

… Patients in the trough-guided group received vancomycin dosed to target a steady-state trough
of 15–20 mg/L, and patients … proportion of patients in the AUC-guided group were obese, …

… continuous infusion, a steady state was achieved faster than that with discontinuous
administrations. Moreover, in polytrauma patients, achieving a steady state … in obese patients, …

… pharmacokinetics of meropenem and/or piperacillin/tazobactam administered by continuous
infusion … assessing the meropenem or piperacillin plasma steady-state concentration (C ss )…

… intermittent infusion and up to 4ámg/L for extended infusion, … order kinetics using near
steady-state postdistributional peak and … Aástandard high-fat/high-calorie meal had no meaningful …

… to either continuous infusion of piperacillin-tazobactam with TDM, … is administered as
continuous infusion, steady-state … in patients with augmented renal clearance, obesity (ie BMI > 40 …

… was collected from each patient after at least three doses of medication (at steady state). The
… Considering the current situation where continuous infusion is difficult to maintain in infants …

… in specific clinical settings (eg critically ill or obese patients). … and Vd at steady state were
higher in CF patients than in healthy … piperacillin CL was observed during continuous infusion …

… (5) In order to build from the theme that continuous infusions … concentrations were assessed
at steady state, we commonly … AUC in obese patients. Empiric maintenance doses for most …

… continuous infusion [20] or as 3-h prolonged infusions every 6 h [25]. An observational study
found that continuous infusions of 12 g/1.5 g piperacillin/tazobactam … evaluated patients with …